ZLSC.F Stock Overview
Manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
ZYUS Life Sciences Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.74 |
| 52 Week High | CA$0.81 |
| 52 Week Low | CA$0.56 |
| Beta | 0 |
| 1 Month Change | 3.18% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -4.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| ZLSC.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -4.0% | 0.02% | -0.6% |
| 1Y | n/a | 15.2% | 22.5% |
Return vs Industry: Insufficient data to determine how ZLSC.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how ZLSC.F performed against the US Market.
Price Volatility
| ZLSC.F volatility | |
|---|---|
| ZLSC.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: ZLSC.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ZLSC.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Brent Zettl | www.zyus.com |
ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada and internationally. The company offers cannabinoid oils, softgel capsules, and topical creams. ZYUS Life Sciences Corporation was founded in 2018 and is based in Saskatoon, Canada.
ZYUS Life Sciences Corporation Fundamentals Summary
| ZLSC.F fundamental statistics | |
|---|---|
| Market cap | US$56.15m |
| Earnings (TTM) | -US$30.15m |
| Revenue (TTM) | US$283.98k |
188.6x
P/S Ratio-1.8x
P/E RatioIs ZLSC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZLSC.F income statement (TTM) | |
|---|---|
| Revenue | CA$387.00k |
| Cost of Revenue | CA$2.39m |
| Gross Profit | -CA$2.00m |
| Other Expenses | CA$39.09m |
| Earnings | -CA$41.09m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.58 |
| Gross Margin | -517.31% |
| Net Profit Margin | -10,618.35% |
| Debt/Equity Ratio | 34.1% |
How did ZLSC.F perform over the long term?
See historical performance and comparison